The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
2014 · Journal of Ovarian Research · 44 citations
https://doi.org/10.1186/1757-2215-7-48
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Hiromi Izawa is an academic researcher.
https://doi.org/10.1186/1757-2215-7-48
https://doi.org/10.3177/jnsv.70.359
Click to start Chat